Cargando…

Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study

BACKGROUND: There is limited guidance for using common drug therapies in the context of multimorbidity. In part, this is because their effectiveness for patients with specific comorbidities cannot easily be established using subgroup analyses in clinical trials. Here, we use simulations to explore t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hannigan, Laurie J., Phillippo, David M., Hanlon, Peter, Moss, Laura, Butterly, Elaine W., Hawkins, Neil, Dias, Sofia, Welton, Nicky J., McAllister, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777306/ https://www.ncbi.nlm.nih.gov/pubmed/34407672 http://dx.doi.org/10.1177/0272989X211029556

Ejemplares similares

Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022)

Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
por: Hanlon, Peter, et al.
Publicado: (2019)

Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023)

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021)

Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis
por: Butterly, Elaine W., et al.
Publicado: (2023)

Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials
por: Lees, Jennifer S, et al.
Publicado: (2022)

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol
por: Butterly, Elaine, et al.
Publicado: (2022)

Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
por: Crowther, Jamie, et al.
Publicado: (2023)

Equivalence of entropy balancing and the method of moments for matching‐adjusted indirect comparison
por: Phillippo, David M., et al.
Publicado: (2020)

Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study
por: Phillippo, David M., et al.
Publicado: (2020)

Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study”
por: Phillippo, David M., et al.
Publicado: (2021)

Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020)

Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis
por: Hanlon, Peter, et al.
Publicado: (2020)

Sensitivity of treatment recommendations to bias in network meta‐analysis
por: Phillippo, David M., et al.
Publicado: (2017)

Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020)

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
por: Phillippo, David M., et al.
Publicado: (2017)

Evidence Synthesis for Decision Making 3: Heterogeneity—Subgroups, Meta-Regression, Bias, and Bias-Adjustment
por: Dias, Sofia, et al.
Publicado: (2013)

Estimation of Coast-Wide Population Trends of Marbled Murrelets in Canada Using a Bayesian Hierarchical Model
por: Bertram, Douglas F., et al.
Publicado: (2015)

Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis
por: Phillippo, David M., et al.
Publicado: (2022)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Exploring Treatment by Covariate Interactions Using Subgroup Analysis and Meta-Regression in Cochrane Reviews: A Review of Recent Practice
por: Donegan, Sarah, et al.
Publicado: (2015)

Multilevel network meta‐regression for population‐adjusted treatment comparisons
por: Phillippo, David M., et al.
Publicado: (2020)

Does Mortality Vary between Asian Subgroups in New Zealand: An Application of Hierarchical Bayesian Modelling
por: Jatrana, Santosh, et al.
Publicado: (2014)

Bayesian analysis of meta-analytic models incorporating dependency: new approaches for the hierarchical Bayesian delta-splitting model
por: Junaidi, et al.
Publicado: (2020)

A flexible Bayesian hierarchical model of preterm birth risk among US Hispanic subgroups in relation to maternal nativity and education
por: Kaufman, Jay S, et al.
Publicado: (2011)

Differences in relative and absolute effectiveness of oral P2Y(12) inhibition in men and women: a meta-analysis and modelling study
por: Lee, Kuan Ken, et al.
Publicado: (2018)

Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing
por: Best, Nicky, et al.
Publicado: (2021)

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
por: Sullivan, Michael K., et al.
Publicado: (2022)

COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study
por: Hanlon, Peter, et al.
Publicado: (2021)

Identifying subgroups of persons with multimorbidity based on their needs for care and support
por: Rijken, Mieke, et al.
Publicado: (2019)

Hierarchical Censored Bayesian Analysis of Visual Field Progression
por: Montesano, Giovanni, et al.
Publicado: (2021)

Gsslasso Cox: a Bayesian hierarchical model for predicting survival and detecting associated genes by incorporating pathway information
por: Tang, Zaixiang, et al.
Publicado: (2019)

Multimorbidity: constellations of conditions across subgroups of midlife and older individuals, and related Medicare expenditures
por: Koroukian, Siran M., et al.
Publicado: (2017)

Bayesian hierarchical modelling for inferring genetic interactions in yeast
por: Heydari, Jonathan, et al.
Publicado: (2015)

Hierarchical Bayesian myocardial perfusion quantification
por: Scannell, Cian M., et al.
Publicado: (2020)

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
por: Sullivan, Michael K., et al.
Publicado: (2021)

The impact of childhood malnutrition on mortality from pneumonia: a systematic review and network meta-analysis
por: Kirolos, Amir, et al.
Publicado: (2021)

Cross-validation to select Bayesian hierarchical models in phylogenetics
por: Duchêne, Sebastián, et al.
Publicado: (2016)

Bayesian hierarchical models for disease mapping applied to contagious pathologies
por: Coly, Sylvain, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events
por: Keeney, Edna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38egomk1qj6m02e1b9qcrg88l2